Objectives: To compare the clinical effectiveness of the intravesical administration of combined hyaluronic acid and chondroitin sulfate (HA+CS) versus current standard management in adult women with recurrent urinary tract infections (RUTIs).
Setting: A European Union-based multicentre, retrospective nested case-control study.
Participants: 276 adult women treated for RUTIs starting from 2009 to 2013.